1.
Tommasini A, Cancrini C, Trizzino A, Drago V, Lazzara F, Platania CBM, Lougaris V. PI3Kδ inhibition treatment of APDS: efficacy, safety and tolerability of targeted therapy with leniolisib. IJPAI [Internet]. 2025 Jan. 22 [cited 2025 Feb. 23];38(4). Available from: https://www.riaponline.it/article/view/588